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Oxidative Stress and “Senescent” 
Fibroblasts in Non-Healing Wounds 
as Potential Therapeutic Targets
Richard A.F. Clark1
In chronic wounds, fibroblast dysfunctions, such as increased apoptosis, 
premature senescence, senescence-like phenotype, or poor growth response in 
the absence of senescence markers, have been reported.   Some of these differ-
ential dysfunctions may be secondary to differences in patient age or sex, ulcer 
size or duration, edge versus base sampling, or culture technique.  Nevertheless, 
the entire spectrum of fibroblast dysfunction may exist and be secondary to, or 
a response to, different amounts of oxidative stress. 
Journal of Investigative Dermatology (2008), 128, 2361–2364. doi:10.1038/jid.2008.257
In their article entitled “Fibroblast 
dysfunction is a key factor in the non- 
healing of chronic venous leg ulcers,” 
Wall et al. (2008, this issue) demon-
strate that a telomere-independent 
fibroblast abnormality occurs in chronic 
venous leg ulcers and posit that oxida-
tive stress underlies this dysfunctional 
behavior. Although it is dysfunctional, 
the authors have clearly emphasized 
both here and in a previous publication 
(Stephens et al., 2003) that the chronic 
wound fibroblast phenotype observed 
by them does not represent the replica-
tive senescence-like phenotype as has 
been reported for chronic wound fibro-
blasts by a number of other investiga-
tors (Agren et al., 1999; Mendez et al., 
1998; Stanley and Osler, 2001; Stanley 
et al., 1997; Vande Berg et al., 1998, 
2005). However, Stephens’s group iso-
lated their chronic wound fibroblasts 
from biopsy specimens that come from 
the ulcer base while all other groups 
harvested chronic wound fibroblasts 
from the ulcer edge. Given the hetero-
geneity in growth response and other 
functions among human fibroblasts 
derived from either papillary or reticu-
lar dermis (Harper and Grove, 1979; 
Sorrell et al., 2008; Sorrell and Caplan, 
2004), it is not surprising that Stephens’s 
group has identified a different chronic 
wound fibroblast phenotype from the 
ulcer bed than the previously described 
fibroblast phenotype from the ulcer 
margin.
Nevertheless, the fibroblast pheno-
types reported by all groups of investi-
gators are consistent with the variety of 
functional changes that can be induced 
by oxidative stress on fibroblasts 
(Wlaschek and Scharffetter-Kochanek, 
2005). As pointed out by Wall et al. 
(2008), the oxidative effects on fibro-
blast phenotype and function depend 
on the level and length of exposure 
to reactive oxygen species (ROS). 
Low-level, chronic exposure to ROS 
accelerates telomere shortening (von 
Zglinicki, 2002), whereas high levels 
of ROS induce telomere-independent 
premature senescence (Song et al., 
2005). Another important aspect of the 
cell “senescence” response to oxida-
tive stress is cell age; aged human der-
mal fibroblasts demonstrate increased 
entrance into a senescent state com-
pared with their younger counter-
parts when exposed to oxidative stress 
(Gurjala et al., 2005). Furthermore, 
depending on the physiologic state of 
the cell, oxidative stress can induce 
apoptosis rather than senescence (Chen 
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et al., 2000). Because chronic wounds 
demonstrate findings that indicate the 
presence of increased ROS (Wlaschek 
and Scharffetter-Kochanek, 2005), it is 
certainly possible that the dysfunctional 
fibroblast phenotypes reported at ulcer 
margins and the ulcer base are both 
attributable to oxidative stress.
ROS can be generated by a variety of 
sources, including H2O2 during purine 
catabolism (xanthine and hypoxanthine 
oxidase) and superoxide (O2
−) during 
mitochondrial metabolism in all cells 
or the respiratory burst associated with 
microbiocidal activity in phagocytes 
(Wlaschek and Scharffetter-Kochanek, 
2005; Wulf, 2002). Importantly, accord-
ing to Wall et al. (2008), chronic wound 
fibroblasts generate elevated levels of 
ROS compared with normal dermal 
fibroblasts, setting up a positive feed-
back system for wound degeneration.
To understand the mechanisms of 
ROS-induced alteration and damage 
to cells, it is important to know that 
hydroxyl (OH·) and peroxy radicals 
(OOH·) are generated from O2
− and 
H2O2 via superoxide dismutase (SOD) 
and the Fenton reaction, respective-
ly (Wulf, 2002). SOD generates one 
oxygen molecule and one hydrogen 
peroxide molecule (H2O2) from two 
superoxide molecules (O2
−) by the fol-
lowing reactions, where M is a transi-
tion metal that oscillates between its 
oxidized and reduced state:
M(n + 1)+ − SOD + O2
− →  
Mn+ − SOD + O2
Mn+ − SOD + O2
− + 2H+ →  
M(n + 1)+ − SOD + H2O2
The Fenton reaction converts H2O2 to 
hydroxyl and peroxy radicals via the 
following reactions:
Fe2+ + H2O2 → Fe3+ + OH· + OH−
Fe3+ + H2O2 → Fe2+ + OOH· + H+
In the Fenton reaction, the transition 
metal is iron, which oscillates between 
its reduced and oxidized states. 
Hydrogen peroxide (H2O2) is relatively 
long-lived in the cell until it is reduced 
by catalase in the perioxisome or by 
glutathione peroxidase in the cyto-
plasm by the following reactions, 
respectively, where GSH is reduced 
glutathione and GSSG is oxidized 
glutathione:
2H2O2 → 2H2O + O2  
(catalase mediated)
2GSH + H2O2 → GSSG + 2H2O  
(glutathione peroxidase mediated)
Because of its relatively long life 
span, H2O2 can act as an effector in 
signal transduction pathways (Wulf, 
2002). Examples of genes induced 
by ROS (probably primarily H2O2) 
include peroxyredoxin I (a thioredoxin 
peroxidase that is protective against 
oxidative stress and apoptosis), heme 
oxygenase-1 (HO-1), and the cystine 
transporter xc
–. The redox control of the 
HO-1 gene is one of the best-studied 
models of redox regulation. For exam-
ple, in dermal fibroblasts HO-1 induc-
tion may serve as an inducible defense 
pathway to remove oxidant-liberated 
heme, which is extremely toxic when 
free (Kumar and Bandyopadhyay, 2005). 
Interestingly, heme toxicity probably is 
attributable in large part to its iron core, 
which, when released in great abun-
dance, overwhelms the iron-binding 
capacity in blood and tissue (i.e., ferri-
tin) and therefore can act as a catalyst 
in the Fenton reaction to generate more 
ROS. Because HO-1 mRNA is induc-
ible in many tissues and its expression 
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figure 1. Lipid peroxidation refers to the 
oxidative degradation of lipids. It is the process 
whereby free radicals “steal” electrons from 
the lipids in cell membranes, resulting in cell 
damage. This process proceeds by a free radical 
chain reaction mechanism. It most often affects 
polyunsaturated fatty acids, because they contain 
multiple double bonds between which lie reactive 
hydrogens. As with any radical reaction, the 
reaction consists of three major steps: initiation, 
propagation, and termination. (From “Lipid 
peroxidation,” Wikipedia, http://en.wikipedia.org/
wiki/Lipid_peroxidation, with permission.)
figure 2. Protein oxidation by free radicals. (a) Hydrogen atom elimination at the α-carbon of the 
protein backbone, resulting in backbone fragmentation, or (b) hydrogen atom elimination at side chains, 
resulting in different products, including peroxides, alcohols, and carbonyls. As with lipid perioxidation, 
protein peroxides are unstable and propagate further reactions. (Modified from the presentation “Protein 
Oxidation: Concepts, Mechanisms and New Insights,” by M.J. Davies, Heart Research Institute, Sydney, 
Australia, with permission.)
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is relatively stable, it is a useful marker 
for cellular oxidative stress.
As previously stated, ROS can 
induce cell apoptosis, and this appears 
to be mediated by H2O2 through its 
activation of the c-Jun N-terminal 
kinase (JNK) pathway, a subgroup of 
the mitogen-activated protein kinase 
family (Shen and Liu, 2006). In gener-
al, JNK is activated by environmental 
stresses, including osmotic shock, 
UV radiation, heat shock, oxidative 
stress, and chemotherapeutic agents, 
as well as the cell death ligands FasL 
and tumor necrosis factor-α and pro-
inflammatory cytokines such as inter-
leukin-1. Among these inducers of 
JNK, however, oxidative stress seems 
particularly important. Although acti-
vated JNK induces a large family of 
genes, its pro-apoptotic activity is more 
direct (Shen and Liu, 2006). In stressed 
cells activated JNK translocates to the 
mitochondria, where it phosphory-
lates and inhibits the anti-apoptotic 
factor Bcl-2 and phosphorylates and 
activates the pro-apoptotic agents Bax, 
Bim, and Bmf. The alteration in bal-
ance between pro- and anti-apoptotic 
factor activities results in the release of 
cytochrome c from the mitochondria 
into the cytoplasm. Subsequently, free 
cytoplasmic cytochrome c activates 
the downstream effectors of the intrin-
sic (mitochondrial) apoptosis pathway.
Some years ago, it was thought that 
H2O2 was the primary positive effector of 
transcription factor NF-κB, a central regu-
lator of immunity, inflammation, and cell 
survival, and that many of the negative 
effects of ROS were mediated through 
NF-κB, including expression of inflam-
matory cytokines such as IL-1, IL-6, IL-8, 
and tumor necrosis factor-α. However, 
new evidence demonstrates that NF-κB 
exerts negative control on ROS and JNK 
activities and may prevent apoptosis that 
ROS would otherwise induce through 
JNK (Bubici et al., 2006).
Not all signal transduction pro-
teins are positively regulated by 
H2O2. Interestingly, hypoxia-inducible 
factor 1 (HIF-1) is negatively regulated 
by this ROS. HIF-1α and HIF-1β genes 
are constitutively expressed, but under 
normoxic conditions HIF-1α is rap-
idly degraded by proteasomes in an 
ROS-dependent manner (Wulf, 2002). 
Hypoxia decreases the ROS-mediated 
degradation of HIF-1α and thereby 
enhances the formation of the hetero-
dimeric complex leading to HIF-1-
dependent gene regulation. Many of 
the gene targets of HIF-1 are important 
positive regulators of wound healing. 
In particular, HIF-1 increases the tran-
scription of key factors for blood flow, 
including vascular endothelial growth 
factor, HO-1, and both endothelial 
and inducible nitric oxide synthase 
(Hellwig-Bürgel et al., 2005). Thus, in 
the presence of oxidative stress these 
HIF-1-inducible genes will remain 
repressed. Parenthetically, it should be 
pointed out that nitric oxide, a reactive 
nitrogen species, is also a potent medi-
ator of signal transduction systems, but 
a discussion of this important topic is 
beyond the scope of this Commentary.
Hydroxyl and peroxy radicals, in 
contrast to H2O2, are extremely short 
lived and essentially react with the 
first susceptible molecule with which 
they collide. Thus, these so-called free 
radicals damage cells directly by lipid 
peroxidation (Figure 1), protein oxida-
tion (Figure 2), and scission of DNA 
single strands (Figure 3), although the 
figures oversimplify the actual pro-
cesses. For example, hydroxyl radials 
can attack purines and pyrimidines, 
leading to gene mutations as well as 
the deoxy ribosyl sugar in the DNA 
backbone (Wulf, 2002). It is impor-
tant to emphasize that telomeres are 
particularly sensitive to DNA breaks 
because they have no DNA repair 
enzyme system (Wulf, 2002). Another 
important example of the biologic 
consequences of ROS-generated free 
radicals is hydroxyl radical attack on 
endothelial cell membranes. In addi-
tion to compromising the membrane 
itself, hydroxyl radicals appear to 
directly activate intracellular calcium-
dependent adhesion molecule on the 
membrane, which makes the endothe-
lium “stickier” for leukocytes passing 
in the circulation (Sellak et al., 1994). 
This both slows blood flow through the 
wound’s microvascular circulation and 
leads to an influx of inflammatory cells 
into the wound.
Given all the adverse consequences 
of elevated ROS levels on cell machin-
ery, it is no wonder that fibroblasts iso-
lated from ROS-rich chronic wounds 
have a dysfunctional phenotype. These 
ongoing pathobiologic events in chronic 
wounds raise the question of how drug 
therapy can attenuate the impact of 
excessive ROS generation. Logically, the 
main target should be one or more of the 
pathways that generate ROS rather than 
dysfunctional chronic wound fibroblasts. 
If the hypothesis of Wall et al. (2008) 
is correct, relieving oxidative stress in 
chronic wounds will ameliorate fibro-
blast dysfunction. Here, clinicians and 
patients are fortunate to have a readily 
available drug that appears to attenuate 
oxidative stress in chronic wounds.
figure 3. Dna single-strand breaks are the most common damage inflicted by ros. The break results 
from collapse of the sugar that is illustrated in the process at the right. (Modified from the presentation 
“DNA Oxidation: A Simple Overview," by F.Q. Schafer, University of Iowa, with permission.)
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Pentoxifylline has been used for 
patients with venous leg ulcers for two 
decades, and a recent meta-analysis 
by the Cochrane Collaborative Group 
found that pentoxifylline was effective 
with a high level of certainty (Jull et al., 
2007). Although the mechanisms of 
action of this drug have not been rigor-
ously defined, they include scavenging 
hydroxyl radicals (Freitas and Filipe, 
1995), inhibiting xanthine oxidase 
(Hammerman et al., 1999), and reduc-
ing circulating levels of tumor necrosis 
factor-α (Fernandes et al., 2008; Zeni 
et al., 1996). Surprisingly, no other 
antioxidants have been tested in well-
controlled clinical trials for efficacy in 
venous leg ulcer disease.
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